Metformin reverses hexokinase and phosphofructokinase downregulation and intracellular distribution in the heart of diabetic mice.
Da Silva, Daniel; Ausina, Priscila; Alencar, Edgard M; Coelho, Wagner S; Zancan, Patricia; Sola-Penna, Mauro.
; 64(9): 766-74, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22730258
Metformin Regulates the Expression of SK2 and SK3 in the Atria of Rats With Type 2 Diabetes Mellitus Through the NOX4/p38MAPK Signaling Pathway.
Of mice and men: models and mechanisms of diabetic cardiomyopathy.
Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.
Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice.
Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.
Tetrahydrocurcumin Ameliorates Diabetic Cardiomyopathy by Attenuating High Glucose-Induced Oxidative Stress and Fibrosis via Activating the SIRT1 Pathway.
Catalase ameliorates diabetes-induced cardiac injury through reduced p65/RelA- mediated transcription of BECN1.
Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.